# Ajinomoto Company Inc. - Inspection Records

Source: https://www.keypedia.com/companies/ajinomoto-company-inc/f1a6a55e-d3b0-4a4e-b3ca-9858a9ca10b6

> Inspection records and compliance data for Ajinomoto Company Inc. in Kawasaki-shi, Kanagawa. Access full analysis and detailed observations.

---

## Details

- Name: Ajinomoto Company Inc.
- FEI Number: 3002806336
- City: Kawasaki-shi
- State: Kanagawa
- Country Name: Japan
- Address Line 1: 1-1
- Address Line 2: Suzuki-Cho, Kawasaki-Ku
- Zip Code: 210-8680
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING

## Related Documents

- [483 - Ajinomoto Company Inc. - 2025-02-21](https://www.keypedia.com/records/483/ajinomoto-company-inc/3bb65a8d-3705-45ab-943d-7c4237edf495) — source: FDA, date: February 21, 2025
- [483 - Ajinomoto Company Inc. - 2025-02-21](https://www.keypedia.com/records/483/ajinomoto-company-inc/c7697083-0d35-48c4-b56a-9c16507a4735) — source: FDA, date: February 21, 2025
- [FDA Inspection 1261618 - Ajinomoto Company Inc. - 2025-02-21](https://www.keypedia.com/records/fda_inspections/ajinomoto-company-inc/2d8a2006-15fa-40cd-aead-dcc1c5559e93) — source: FDA, date: February 21, 2025
- [FDA Inspection 1261618 - Ajinomoto Company Inc. - 2025-02-21](https://www.keypedia.com/records/fda_inspections/ajinomoto-company-inc/8a2031a0-1843-4098-8e60-52955466c779) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 21, 2025
- [483 - Ajinomoto Company Inc. - 2025-02-17](https://www.keypedia.com/records/483/ajinomoto-company-inc/476b776a-5bbc-4d29-9483-83e58389fbdf) — source: FDA, date: February 17, 2025
- [EIR - Ajinomoto Company Inc. - 2019-11-08](https://www.keypedia.com/records/eir/ajinomoto-company-inc/7a24a9bd-4325-4553-b2c7-62f9ada05ba7) — source: FDA, date: November 8, 2019
- [EIR - Ajinomoto Company Inc. - 2019-11-08](https://www.keypedia.com/records/eir/ajinomoto-company-inc/bca20f82-a988-46e5-82f6-ba626e7c3443) — source: FDA, date: November 8, 2019
- [FDA Inspection 1112437 - Ajinomoto Company Inc. - 2019-11-08](https://www.keypedia.com/records/fda_inspections/ajinomoto-company-inc/f73957e4-97ff-411f-a11a-7794285576f6) — classification: No Action Indicated (NAI), source: FDA, date: November 8, 2019
- [EIR - Ajinomoto Company Inc. - 2019-11-05](https://www.keypedia.com/records/eir/ajinomoto-company-inc/8a978076-f62e-4e9b-b222-f1a73068fc1b) — source: FDA, date: November 5, 2019
- [FDA Inspection 1038111 - Ajinomoto Company Inc. - 2017-09-22](https://www.keypedia.com/records/fda_inspections/ajinomoto-company-inc/56c10afe-6719-47b1-bad4-0badcaa55d00) — classification: No Action Indicated (NAI), source: FDA, date: September 22, 2017
- [FDA Inspection 917041 - Ajinomoto Company Inc. - 2015-03-13](https://www.keypedia.com/records/fda_inspections/ajinomoto-company-inc/4a433ebd-60d2-4b1f-a6fb-bded90765eda) — classification: No Action Indicated (NAI), source: FDA, date: March 13, 2015
- [FDA Inspection 798908 - Ajinomoto Company Inc. - 2012-09-13](https://www.keypedia.com/records/fda_inspections/ajinomoto-company-inc/261bcefd-112c-43b9-9dfc-decb11523b96) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 13, 2012
- [FDA Inspection 592985 - Ajinomoto Company Inc. - 2009-05-29](https://www.keypedia.com/records/fda_inspections/ajinomoto-company-inc/204165f1-9f5e-441f-baec-fac95d1ee3aa) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 29, 2009

## Related Companies

- [Nanjing Hanxin Pharmaceutical Technology Co., Ltd.](https://www.keypedia.com/companies/nanjing-hanxin-pharmaceutical-technology-co-ltd/13c8b77b-dfa8-4a49-9362-09743614e722)
- [Symrise, Inc](https://www.keypedia.com/companies/symrise-inc/3c94427e-fd36-4498-bcbd-148093d778bd)
- [Jubilant Pharmova Limited](https://www.keypedia.com/companies/jubilant-pharmova-limited/a01c2832-8b6e-44ba-a73e-dd7649feb936)
- [Merck Life Science Technologies (Nantong) Co., Ltd.](https://www.keypedia.com/companies/merck-life-science-technologies-nantong-co-ltd/37493d9d-656d-4dc2-ab62-650cd0281a8d)
- [Nanjing Cuccess Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/nanjing-cuccess-pharmaceutical-co-ltd/34bd5da4-2efe-4abc-9322-6847e76f7dda)
- [Qilu Pharmaceutical Co., Ltd. (Dongjia Site)](https://www.keypedia.com/companies/qilu-pharmaceutical-co-ltd-dongjia-site/cc92034a-0571-4e14-b26d-03e2efd1cd97)
- [NorthStar Medical Radioisotopes, LLC](https://www.keypedia.com/companies/northstar-medical-radioisotopes-llc/2ae91764-ce9b-4c3f-949b-bce9a564ba89)
- [UCB Pharma S.A.](https://www.keypedia.com/companies/ucb-pharma-sa/6a03badf-6619-4125-b598-85ceebcc8c50)
- [BioMarin Pharmaceutical, Inc.](https://www.keypedia.com/companies/biomarin-pharmaceutical-inc/7811b401-4321-4df1-b9b5-deef8905c101)
- [SMS Lifesciences India Limited](https://www.keypedia.com/companies/sms-lifesciences-india-limited/15b7f08f-5def-4a9b-a74c-6dda7a382c64)

## Related Officers

- [Jogy George](https://www.keypedia.com/people/jogy-george/00ef0915-66d2-4b34-9b74-d1e08caf2db3)
- [company_representative](https://www.keypedia.com/people/kazuyuki-kubota/2f9e196a-7d7c-4330-88e2-d5cb606252b0)
- [issuing_officer](https://www.keypedia.com/people/stephen-j-mottola/a35bf779-9edb-40a3-93c8-1ac43808dccf)
- [company_representative](https://www.keypedia.com/people/hiroshi-tsujita/249cafe3-9072-4f48-bee8-3dcb65ecd124)